Cistrax 5 mg/2.5 ml; 10 mg/5 ml & 150 mg/30 ml Solution for injection or infusion
PDF Leaflet Revision Date: 01 November 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Used during surgical procedures to relax skeletal muscles.
Dosage (summary)
Adults: 0.15 mg/kg for intubation; maintenance 0.03 mg/kg.
Onset of Action / Duration
Onset: 2-8 mins, Duration: approx. 20 mins for maintenance.
Special Populations
- Elderly patients
- Renal impairment
- Hepatic impairment
- ICU patients
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; safety not established.
Key Drug Interactions
- Halogenated anaesthetics
- Aminoglycosides
- Calcium-channel blockers
- Diuretics
- Magnesium salts
Contraindications
- Hypersensitivity to cisatracurium
- Pregnancy
- Lactation
- Neonates
Common side effects
- Bradycardia
- Hypotension
- Anaphylactic reaction
- Muscle weakness
Counselling Points
- Monitor for respiratory function.
- Avoid use with blood transfusion lines.
- Inform about potential allergic reactions.
Serious warnings
- Respiration must be assisted until CISTRAX is inactivated.
- Caution in patients with neuromuscular disorders.
Important Disclaimer
The Cistrax 5 mg/2.5 ml; 10 mg/5 ml & 150 mg/30 ml Solution for injection or infusion professional information leaflet below is the property of Accord Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
